. 2019 Nov 29;10(4):389–395. doi: 10.1016/j.jtcme.2019.11.003

Table 3.

Effects of different treatments on PTPase activities on different tissues in rats.

Parameters	Treatments
Parameters	NC	DC	PC	HCO	LCO
Liver (%)	100.0 ± 3.0^B	129.3 ± 8.9^A	129.2 ± 3.4^A	100.9 ± 8.7^B	104.4 ± 3.4^AB
Muscle (%)	100.0 ± 3.3^B	117.8 ± 7.8^A	104.0 ± 1.7^AB	97.6 ± 3.4^B	108.5 ± 1.2^AB
Perirenal fat (%)	100.0 ± 6.7^A	94.9 ± 4.0^A	102.6 ± 5.8^A	84.8 ± 2.3^A	87.8 ± 3.7^A
Epididymal fat (%)	100.0 ± 8.8^B	160.4 ± 25.7^A	123.2 ± 5.9^AB	96.2 ± 3.0^B	89.0 ± 4.5^B

Results are mean ± SE (n = 6–7). Different letters (A-B) are significantly different (p < 0.05, one-way ANOVA) according to the Tukey’s test. PTPase: Protein tyrosine phosphatase, NC: normal control, DC: diabetic control, PC: 30 mg/kg of pioglitazone, HCO: high-dosage C. obtusa var. formosana leaf extracts, LCO: low-dosage C. obtusa var. formosana leaf extracts.